182400 — NKMax Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro Cap

Annual income statement for NKMax Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	R2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS/A
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	10,372	13,020	11,263	10,769	8,800
Cost of Revenue
Gross Profit	7,292	9,286	8,719	6,386	7,140
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	51,568	60,461	60,916	87,896	43,944
Operating Profit	-41,197	-47,440	-49,653	-77,126	-35,144
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-43,138	-50,095	-56,658	-170,456	-36,760
Provision for Income Taxes
Net Income After Taxes	-41,440	-51,079	-55,607	-158,607	-36,942
Minority Interest
Net Income Before Extraordinary Items
Net Income	-41,439	-50,336	-53,505	-117,108	-36,942
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-41,439	-50,336	-53,505	-117,108	-36,942
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-3,021	-3,359	-3,220	-6,479	-994
Dividends per Share